Generics 36

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Glycopyrrolate manufacturers

36 products found

Filters

36 products found

glycopyrrolate

Vials 0.1 mg/ml - 1 ml, 2 ml, 5 ml, 20 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Comments
Ref: Robinul®
Manufacturer #252

Manufacturer usually replies in 2 days

glycopyrrolate

Vials, injection 0.2 mg / 1 ml, 0.4 mg / 1 ml, 1 mg / 5 ml, 4 mg / 20 ml

Dossier type
US CTD
Dossier status
Ready to file
Country of origin
United States
GMP approvals
FDA
Manufacturer #18871

Manufacturer usually replies in 4 days

glycopyrrolate

Vials, injection 0.2 mg / ml, 0.4 mg / 2 ml

Dossier type
US CTD
Dossier status
Ready to file
Country of origin
United States
GMP approvals
FDA
Manufacturer #18856

Manufacturer usually replies in 3 days

glycopyrrolate

Inhalation powder tbd

Dossier type
US CTD
Dossier status
Ready to file
Country of origin
United States
GMP approvals
FDA
Unavailable markets
United States
Manufacturer #13159

Manufacturer usually replies in 3 days

glycopyrrolate

Inhalation solution tbd

Dossier type
US CTD
Dossier status
Ready to file
Country of origin
United States
GMP approvals
FDA
Unavailable markets
United States
Manufacturer #13159

Manufacturer usually replies in 3 days

glycopyrrolate

Solution for injection 0.6mg/3mL, 1mg/5mL

Dossier type
US CTD
Dossier status
Ready to file
Country of origin
United States
GMP approvals
FDA
Manufacturer #17737

Manufacturer usually replies in 5 days

glycopyrrolate

Tablets 1 mg, 2 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Unavailable markets
United Kingdom
Registered in
United Kingdom
Manufacturer #12311

Manufacturer usually replies in 13 days

glycopyrrolate + neostigmine methylsulfate

Injection 0.5 mg + 2.5 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #21249

Manufacturer usually replies in 5 days

glycopyrrolate

Injection 0.2 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #21249

Manufacturer usually replies in 5 days

glycopyrrolate

Vials, injection 200 mcg/ml - 20 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Available for
Licensing with supply, Distribution only
Manufacturer #18885

Manufacturer usually replies in 7 days

glycopyrrolate

Injection 200 mcg/ml - 1 ml, 3 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP, WHO
Manufacturer #2303

Manufacturer usually replies in 7 days

glycopyrrolate

Solution for injection 0.2 mg/ml - 1 ml, 2 ml, 5 ml, 20 ml

Dossier type
US CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
FDA, EU GMP
Unavailable markets
Peru
Available for
Licensing with supply, Distribution only
Manufacturer #16394

Manufacturer usually replies in 12 days

glycopyrrolate

Injection 0.2 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20087

Manufacturer usually replies in 8 days

glycopyrrolate

Ampoules, injection 0.2 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
South Korea
GMP approvals
PICS
Manufacturer #18075
The mission of all pharmaceutical companies and employees is to fight disease and protect those who suffer or lose their lives. Therefore, the development, production, and supply of excellent pharmaceuticals are a fundamental responsibility of pharmaceutical companies. Based on the research, production, and sales capabilities from API to Drug products using purely their technology, they are leaping to become the global No. 1 bio & chemical-pharmaceutical company in various areas including next-generation biopharmaceuticals, from gene therapy to antibody therapy, cell therapy, and natural medicine.

Manufacturer usually replies in 9 days

glycopyrrolate

Injection 0.2 mg / ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #17417

Manufacturer usually replies in 6 days

glycopyrrolate

Solution for injection 0,2 mg/ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Available for
Licensing with supply
Manufacturer #10323

Manufacturer usually replies in 5 days

glycopyrrolate

Solution for injection 0.2mg/1ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
South Korea
Manufacturer #13135
The company has become a respected global health care group. The company has great growth potential. They use DDS source technology and an excellent pipeline to secure long-term growth. They are focused on profitability in a highly competitive market with new drugs and niche buster product launch technology.

Manufacturer usually replies in 7 days

glycopyrrolate

Vials, injection 0.2 mg/ml - 1 ml, 2 ml, 5 ml, 20 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
FDA, EU GMP, WHO, MHRA
Available for
Licensing with supply
Manufacturer #16394

Manufacturer usually replies in 12 days

glycopyrrolate

Inhalation solution 25 mcg/ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Bangladesh
GMP approvals
WHO
Manufacturer #21340

Manufacturer usually replies in 8 days

glycopyrrolate

Inhaler 50 mcg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Bangladesh
GMP approvals
WHO
Manufacturer #21340

Manufacturer usually replies in 8 days

Want to view all 36 products? Create your free account today!